Inception Return
(7/24/2012)
|
15.12 %
|
|
YTD Return
|
0.79 %
|
|
NAVPS
(5/7/2021)
|
$59.89
|
|
Change
|
$0.07 / 0.12 %
|
|
|
Growth of $10,000
(As of March 31, 2021)
|
|
MER
|
0.33 %
|
|
Assets ($mil)
|
$314.50
|
|
Rank (1Yr)
|
1807/1830
|
|
Std Dev (3Yr)
|
11.23 %
|
|
Volatility Ranking (3Yr)
|
4/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The iShares MSCI USA Minimum Volatility Index Fund seeks to provide long-term capital growth by replicating, to the extent possible, the performance of the MSCI USA Minimum Volatility Index (USD), net of expenses.
|
Management Co.
BlackRock Asset Management Canada Limited
Managers
|
|
Asset Allocation
(As of March 31, 2021)
|
Sector Allocation
(As of March 31, 2021)
|
Geographic Allocation
(As of March 31, 2021)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Johnson & Johnson | US Equity | Healthcare | United States | 1.61% |
| Microsoft Corp | US Equity | Technology | United States | 1.59% |
| Accenture PLC Cl A | International Equity | Technology | European Union | 1.56% |
| Waste Management Inc | US Equity | Industrial Services | United States | 1.55% |
| McDonald's Corp | US Equity | Consumer Services | United States | 1.50% |
| NextEra Energy Inc | US Equity | Utilities | United States | 1.44% |
| Visa Inc Cl A | US Equity | Financial Services | United States | 1.44% |
| Vertex Pharmaceuticals Inc | US Equity | Healthcare | United States | 1.43% |
| Gilead Sciences Inc | US Equity | Healthcare | United States | 1.43% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 1.43% |
Performance Data
(As of March 31, 2021)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
4.69
|
0.79
|
2.64
|
0.79
|
14.57
|
10.75
|
10.52
|
-
|
|
Benchmark
|
3.47
|
4.87
|
12.25
|
4.87
|
38.59
|
15.81
|
15.55
|
16.91
|
|
Quartile Ranking
|
1
|
4
|
4
|
4
|
4
|
3
|
3
|
-
|
|
Calendar Return (%)
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
|
Fund
|
3.27
|
20.60
|
9.98
|
10.60
|
6.05
|
25.87
|
26.15
|
32.64
|
-
|
-
|
|
Benchmark
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
20.77
|
24.19
|
41.93
|
13.16
|
4.41
|
|
Quartile Ranking
|
4
|
3
|
1
|
3
|
2
|
1
|
1
|
4
|
-
|
-
|
MSCI ESG Fund Metrics (As of April 01, 2021)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.